Recent insider trends for Repros Therapeutics Inc. (NASDAQ:RPRX) have caught the attention of investors. Analysts monitor insider data to understand the sentiment of a company’s largest and most important shareholders. RPRX’s insider trading patterns have some implications for where the stock might be headed.
Institutions own 14.52% of Repros Therapeutics Inc. (RPRX)’s shares. The total value of these holdings, in millions, is $3. Among active positions in the latest quarter, 5 holders increased their positions by a total of 373584 shares, 19 holders decreased the positions by a total of 1.28 million shares, and 11 holders held their positions. This works out to a net decrease in ownership of 909280 shares, and suggests that institutions are feeling bearish about the stock.
Among new and sold out positions, 2 holders initiated new positions by a total of 101871 shares and 6 holders exited their positions by a total of 959316 shares. This nets out to a decrease of 857445 shares and is another bearish sign for RPRX.
Insider ownership increased by a total of 0 shares, which suggests that RPRX’s key executives are feeling more optimistic about the outlook for the stock. The data from the past twelve months tells a similar story: insiders executed 12 buys and 1 sells, and ownership increased by a net of 276695 shares.
Analysts often look at short interest, or the number of shares currently being shorted by investors, to aid in their outlook for a particular stock. Repros Therapeutics Inc. (NASDAQ:RPRX)’s short interest is 811800 shares, or % of the float. This represents a decrease of -32% in the number of shares being shorted compared to the previous reading, and implies that investors felt less pessimistic about the stock during the past two weeks.
Given what the insider ownership patterns are saying, it makes sense to consider the technicals to see if these pieces of information reach the same conclusion about the outlook for RPRX. A composite of 13 technical indicators that includes measures such as moving averages and momentum oscillators suggests that RPRX is a Strong buy, which implies that RPRX is expected to outperform the market based on prior trading patterns.
Institutional ownership trends suggest that the stock is cheap and the insider trading data indicates that insiders are bullish. Technical indicators (also) suggest that Repros Therapeutics Inc. (NASDAQ:RPRX) is undervalued.